Severe acneiform rash.
Yamamoto
Deanna Sanchez
DS
Santa Clara Valley Medical Center in San Jose, CA, USA. deannayamamoto@sbcglobal.net
Viale
Pamela Hallquist
PH
Zhao
Gary
G
D017486:Acneiform Eruptions / Q000139:chemically induced* / Q000523:psychology / Q000628:therapy; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000068818:Cetuximab; D015179:Colorectal Neoplasms / Q000188:drug therapy; D004334:Drug Administration Schedule; D003875:Drug Eruptions / Q000209:etiology* / Q000523:psychology / Q000628:therapy; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000502:physiology; D005148:Facial Dermatoses / Q000139:chemically induced* / Q000523:psychology / Q000628:therapy; D005260:Female; D006801:Humans; D024802:Nurse's Role; D009859:Oncology Nursing / Q000379:methods; D012017:Referral and Consultation; D012720:Severity of Illness Index; D013752:Tetracycline / Q000627:therapeutic use; D016312:Treatment Refusal
D000900:Anti-Bacterial Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D066246:ErbB Receptors; D013752:Tetracycline; D000068818:Cetuximab